# STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy

> **NCT00228371** · PHASE2,PHASE3 · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 4 (actual)

## Conditions studied

- Epilepsy
- Drug Resistant

## Interventions

- **DEVICE:** Neurostimulation

## Key facts

- **NCT ID:** NCT00228371
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** insufficent enrolement
- **Last updated:** 2015-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00228371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00228371, "STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00228371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*